Qilu Pharmaceutical Honored as '2025 Shandong Social Responsibility Enterprise' for Sixth Consecutive Year

Six YearsSixThe prestigious honor recognizes Qilu Pharmaceutical's dedication to fulfilling social responsibilities over the past 40 years. Consistently integrating social responsibility into its corporate development, Qilu Pharmaceutical not only safeguards life and health through its medicines but also actively engages in philanthropy with unwavering commitment, demonstrating the accountability expected of a large enterprise.

Staying True to Our Original Aspiration, Demonstrating the Responsibility of Pharmaceutical Professionals. Qilu Pharmaceutical adheres to a clinical demand-oriented approach, prioritizes patients, and integrates "innovation with warmth" into its R&D ethos. During the 14th Five-Year Plan period, the group invested over 20 billion yuan in R&D, with an R&D intensity exceeding 12%, launching 144 new products, including four Class 1 new drugs. To date, the group has launched 350 products, 16 of which are biologics. The company actively participates in national procurement initiatives, winning bids for 109 products—the highest number among Chinese companies—continuously meeting patients' diverse needs for high-quality medications, ensuring that people have access to affordable, effective, and high-quality domestically produced drugs. Additionally, the company promotes the integration of technological innovation and industry by collaborating with organizations such as the National Natural Science Foundation of China and the China Science and Technology Development Foundation. Over 200 million yuan in research funding has been directed toward basic research to jointly address critical challenges, accelerating the transition of scientific achievements from the lab to clinical settings, allowing innovative drugs to benefit patients more quickly.

Green as the Base, Painting a "New Blueprint" for Ecological Pharmaceutical Manufacturing. Qilu Pharmaceutical regards environmental protection as a lifeline of development, treating the ecological environment with the same care as life and researching ways to enhance environmental processes with the same dedication as pharmaceuticals. The company continuously invests heavily in environmental protection to provide solid support for green development. During the "14th Five-Year Plan" period, the group's safety and environmental expenditure reached 25.37 billion yuan, of which 15.84 billion yuan was spent on environmental operation and maintenance. On the production side, the company promotes green manufacturing through intelligence and digitalization, setting a benchmark for green factories by achieving fully automated production processes. On the management side, an SHE management system aligned with international standards has been established, incorporating environmental performance into the assessment of enterprise development quality, forming an environmental management framework of "full staff participation, full-process control, and continuous improvement." During the "14th Five-Year Plan" period, five subsidiaries of the group were awarded the title of "National Green Factory." To date, seven subsidiaries of the group have received the "National Green Factory" designation, and 12 subsidiaries have passed ISO14001 certification, achieving full coverage of production-oriented subsidiaries.

Boundless Love, Building a Long-term Mechanism for Public Welfare and Charity. Qilu Pharmaceutical Co., Ltd. has long been committed to charitable causes, continuously contributing to various social public welfare projects. The company has funded the establishment of a public welfare charity foundation, published social responsibility reports, and designated October 22 as "Qilu Public Welfare Day," creating branded public welfare initiatives such as "Lily Blossoms," "YAO Health," and "Good Deeds in Qilu." Relying on the foundation's platform, the company focuses on four key areas: humanitarian relief, health promotion, educational development, and social participation. It consistently works on poverty alleviation, supporting the elderly, aiding orphans, assisting the sick, helping the disabled, disaster relief, medical aid, and educational support, demonstrating the responsibility and commitment of a large enterprise through concrete actions.

In the future, Qilu Pharmaceutical will continue to practice the core corporate values of "Great doctors are precise and sincere, with a heart for family, country, and the world," assume more social responsibilities, and contribute greater Qilu strength to the advancement of human health and the rise of China's pharmaceutical industry.

Source: Qilu Pharmaceutical Official Account

First Review: Wang Yao | Second Review: Teng Chunyan | Final Review: Liu Bin